A numerical trend toward longer PFS was observed among patients receiving SBRT during immunotherapy, although the differences were not statistically significant.
← all excerpts
Stereotactic Body Radiotherapy for Oligometastatic Disease in Melanoma Patients Receiving Immunotherapy: A Single-Center Retrospective Analysis.
2
—
—
The sentences
Although patients treated before or during immunotherapy appeared to have a longer PFS than those treated after immunotherapy, these differences did not reach statistical significance, likely due to the limited sample size.